These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23317260)

  • 1. Comparison of treatment compliance and nutritional outcomes among patients with nasopharyngeal carcinoma with and without percutaneous endoscopic gastrostomy during chemoradiation.
    Peerawong T; Phungrassami T; Pruegsanusak K; Sangthong R
    Asian Pac J Cancer Prev; 2012; 13(11):5805-9. PubMed ID: 23317260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefits of prophylactic percutaneous gastrostomy in patients with nasopharyngeal cancer receiving concurrent chemoradiotherapy: A multicenter analysis.
    Dechaphunkul T; Ngamphaiboon N; Danchaivijitr P; Jiratrachu R; Geater SL; Pattaranutaporn P; Jiarpinitnun C; Setakornnukul J; Suktitipat B; Dechaphunkul A
    Am J Otolaryngol; 2022; 43(2):103356. PubMed ID: 34972008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous endoscopic gastrostomy can improve survival outcomes in patients with N3 nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy.
    Xu Y; Chen M; Guo Q; Peng H; Guo L; Zong J; Huang H; Chen B; Xu H; Pan J; Lin S
    Oral Oncol; 2021 Oct; 121():105435. PubMed ID: 34271334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Concurrent chemoradiotherapy followed by adjuvant chemotherapy for stage III-IVa nasopharyngeal carcinoma].
    Hu QY; Liu P; Wang L; Fu ZF
    Ai Zheng; 2007 Apr; 26(4):394-7. PubMed ID: 17430659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of efficacy of docetaxel combined cisplatin (TP regimen) and cisplatin combined 5-fluorouracil (PF regimen) on locally advanced nasopharyngeal carcinoma].
    Xie FY; Qi SN; Hu WH; Zou GR; Peng M; Li JS
    Ai Zheng; 2007 Aug; 26(8):880-4. PubMed ID: 17697552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous endoscopic gastrostomy in oropharyngeal cancer patients treated with intensity-modulated radiotherapy with concurrent chemotherapy.
    Romesser PB; Romanyshyn JC; Schupak KD; Setton J; Riaz N; Wolden SL; Gelblum DY; Sherman EJ; Kraus D; Lee NY
    Cancer; 2012 Dec; 118(24):6072-8. PubMed ID: 22707358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of lobaplatin combined with 5-fluorouracil as first-line induction chemotherapy followed by lobaplatin-radiotherapy in locally advanced nasopharyngeal carcinoma: preliminary results of a prospective phase II trial.
    Ke LR; Xia WX; Qiu WZ; Huang XJ; Yang J; Yu YH; Liang H; Liu GY; Ye YF; Xiang YQ; Guo X; Lv X
    BMC Cancer; 2017 Feb; 17(1):134. PubMed ID: 28202000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent chemoradiation followed by adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma in Korea.
    Park KH; Kim JS; Park Y; Seo HY; Park YJ; Choi IK; Oh SC; Seo JH; Kim CY; Jung KY; Shin SW; Kim YH; Kim JS; Lee NJ
    Cancer Chemother Pharmacol; 2010 Sep; 66(4):643-51. PubMed ID: 20033411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of prophylactic percutaneous endoscopic gastrostomy tube in head and neck cancer patients undergoing concurrent chemoradiation: A prospective observational cohort.
    Dechaphunkul T; Soonthornrak P; Geater SL; Dechaphunkul A
    Am J Otolaryngol; 2022; 43(4):103512. PubMed ID: 35636089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of induction docetaxel, platinum, and fluorouracil chemotherapy in patients with stage III or IVA/B nasopharyngeal cancer treated with concurrent chemoradiation therapy: Final results of 2 parallel phase 2 clinical trials.
    Kong L; Zhang Y; Hu C; Guo Y; Lu JJ
    Cancer; 2017 Jun; 123(12):2258-2267. PubMed ID: 28192641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycididazole sodium combined with radiochemotherapy for locally advanced nasopharyngeal carcinoma.
    Li MY; Liu JQ; Chen DP; Qi B; Liang YY; Yin WJ
    Asian Pac J Cancer Prev; 2014; 15(6):2641-6. PubMed ID: 24761877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of prophylactic percutaneous endoscopic gastrostomy with reactive enteral nutrition in patients with head and neck cancer undergoing radiotherapy or chemoradiotherapy: A systematic review.
    Mellors K; Ye X; Van Den Brande J; Wai Ray Mak T; Brown T; Findlay M; Bauer J
    Clin Nutr ESPEN; 2021 Dec; 46():87-98. PubMed ID: 34857252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction chemotherapy followed by alternating chemo-radiotherapy in non-endemic undifferentiated carcinoma of the nasopharynx: optimal compliance and promising 4-year results.
    Ponzanelli A; Vigo V; Marcenaro M; Bacigalupo A; Gatteschi B; Ravetti JL; Corvò R; Benasso M
    Oral Oncol; 2008 Aug; 44(8):767-74. PubMed ID: 18061519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma: a retrospective controlled study.
    Qiu WZ; Huang PY; Shi JL; Xia HQ; Zhao C; Cao KJ
    Chin J Cancer; 2016 Jan; 35():2. PubMed ID: 26739148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carboplatin/5-fluorouracil as an alternative to cisplatin/5- fluorouracil for metastatic and recurrent head and neck squamous cell carcinoma and nasopharyngeal carcinoma.
    Kua VF; Ismail F; Chee Ee Phua V; Aslan NM
    Asian Pac J Cancer Prev; 2013; 14(2):1121-6. PubMed ID: 23621198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting outcomes of alternating chemoradiotherapy for nasopharyngeal cancer.
    Ueno T; Endo K; Kondo S; Wakisaka N; Murono S; Ito M; Yoshizaki T
    Ann Otol Rhinol Laryngol; 2014 Jul; 123(7):509-16. PubMed ID: 24634152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodal treatment, including interferon beta, of nasopharyngeal carcinoma in children and young adults: preliminary results from the prospective, multicenter study NPC-2003-GPOH/DCOG.
    Buehrlen M; Zwaan CM; Granzen B; Lassay L; Deutz P; Vorwerk P; Staatz G; Gademann G; Christiansen H; Oldenburger F; Tamm M; Mertens R
    Cancer; 2012 Oct; 118(19):4892-900. PubMed ID: 22359313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute toxicity in nasopharyngeal carcinoma patients treated with IMRT/VMAT.
    Ozdemir S; Akin M; Coban Y; Yildirim C; Uzel O
    Asian Pac J Cancer Prev; 2015; 16(5):1897-900. PubMed ID: 25773841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of definite chemoradiation therapy with carboplatin/paclitaxel or cisplatin/5-fluoruracil in patients with squamous cell carcinoma of the esophagus.
    Münch S; Pigorsch SU; Devečka M; Dapper H; Weichert W; Friess H; Braren R; Combs SE; Habermehl D
    Radiat Oncol; 2018 Aug; 13(1):139. PubMed ID: 30068371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of induction chemotherapy with vinorelbine plus cisplatin (NP) or docetaxel plus cisplatin (TP) combined with concurrent chemoradiotherapy for patients with locally advanced nasopharyngeal carcinoma].
    Han SH; Yu L; Zhang Z; Zhang PJ; Song HP; Guo CY
    Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):623-6. PubMed ID: 24314223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.